Results 181 to 190 of about 5,858 (232)
Some of the next articles are maybe not open access.
European Journal of Pharmacology, 2022
Acetylcholinesterase (AChE) inhibitor (AChEI) is well established as first-line agents for relieving the symptoms of Alzheimer's disease (AD). Injectable sustained-release formulation of AChEI may be suitable for treating AD patients. However, it needs to
Ce Zhang +6 more
semanticscholar +1 more source
Acetylcholinesterase (AChE) inhibitor (AChEI) is well established as first-line agents for relieving the symptoms of Alzheimer's disease (AD). Injectable sustained-release formulation of AChEI may be suitable for treating AD patients. However, it needs to
Ce Zhang +6 more
semanticscholar +1 more source
Journal of Natural Products, 2021
The first systematic direct diversification of a complex natural product by metal-catalyzed N-H functionalization was carried out. A new series of N-(hetero)aryl analogues (1-32) of the natural anti-Alzheimer's disease drug huperzine A (HPA) was prepared
Shi-Xing Miao +5 more
semanticscholar +1 more source
The first systematic direct diversification of a complex natural product by metal-catalyzed N-H functionalization was carried out. A new series of N-(hetero)aryl analogues (1-32) of the natural anti-Alzheimer's disease drug huperzine A (HPA) was prepared
Shi-Xing Miao +5 more
semanticscholar +1 more source
Rapid Communications in Mass Spectrometry
RATIONALE N-[2-Hydroxy-3,5-dimethylbenzilidene]-Hup A (H14) is a derivative of huperzine A (Hup A) that demonstrates superior protective effects against soman (GD) compared to Hup A. This study aims to evaluate the protective efficacy of H14 pretreatment
Guixiang Yang +9 more
semanticscholar +1 more source
RATIONALE N-[2-Hydroxy-3,5-dimethylbenzilidene]-Hup A (H14) is a derivative of huperzine A (Hup A) that demonstrates superior protective effects against soman (GD) compared to Hup A. This study aims to evaluate the protective efficacy of H14 pretreatment
Guixiang Yang +9 more
semanticscholar +1 more source
Phytotherapy Research, 2021
Cognitive impairments are a part of the neurocognitive disorders which deteriorate the normal cognitive function. An overview of systematic reviews (SRs) was conducted to summarize the findings of SRs and meta‐analyses on the effectiveness of Huperzine A
Nafiseh Ghassab-Abdollahi +4 more
semanticscholar +1 more source
Cognitive impairments are a part of the neurocognitive disorders which deteriorate the normal cognitive function. An overview of systematic reviews (SRs) was conducted to summarize the findings of SRs and meta‐analyses on the effectiveness of Huperzine A
Nafiseh Ghassab-Abdollahi +4 more
semanticscholar +1 more source
Synthesis of (±)-desamino huperzine A
Tetrahedron Letters, 2000The first synthesis of desamino huperzine A 2 is described. Key steps are a double Michael addition into benzoquinone monoketal 4, a regiocontrolled double bond isomerisation and a novel pyridone synthesis involving a Michael addition of a ß-keto ester into acrylonitrile. (C) 2000 Elsevier Science Ltd.
Högenauer, Klemens +2 more
openaire +1 more source
Synthesis of a hybrid analog of the acetylcholinesterase inhibitors huperzine A and huperzine B
Tetrahedron Letters, 2001Abstract The synthesis of a new hybrid analog of the acetylcholinesterase (AChE) inhibitors huperzine A and B is reported. An intramolecular reductive dicarbonyl coupling was used as a key reaction for constructing the tetracyclic ring system.
V Rajendran +4 more
openaire +1 more source
International Journal of Biological Macromolecules
Huperzine A (HupA) is used in Alzheimer's disease (AD) therapy for its effective inhibition of acetylcholinesterase (AChE) and enhancement of cholinergic neuronal function. However, direct oral administration and injection of HupA cause side effects like
Daixu Wei +6 more
semanticscholar +1 more source
Huperzine A (HupA) is used in Alzheimer's disease (AD) therapy for its effective inhibition of acetylcholinesterase (AChE) and enhancement of cholinergic neuronal function. However, direct oral administration and injection of HupA cause side effects like
Daixu Wei +6 more
semanticscholar +1 more source
Microbial transformation of (−)-Huperzine A
Tetrahedron Letters, 2010Five products were yielded from the transformation of (−)-Huperzine A (1) by Streptomyces griseus CACC 200300. Their structures were determined as 16-hydroxyl huperzine A (2), 14α-hydroxyl huperzine A (3), huperzine A 8α,15α-epoxide (4), 13N-formyl huperzine A (5), and 13N-acetyl huperzine A (6) on the basis of their chemical and physical data.
Xinyuan Zhang, Jian-hua Zou, Jungui Dai
openaire +1 more source
Neurochemistry International, 2022
The multimodal MRI and 1H MRS study was designed to provide a structural and neurochemical view of D-galactose induced rat brain degeneration and its treatment with huperzine A. The volume changes were captured using MRI focused on the hippocampal region
Lubomir Melichercik +6 more
semanticscholar +1 more source
The multimodal MRI and 1H MRS study was designed to provide a structural and neurochemical view of D-galactose induced rat brain degeneration and its treatment with huperzine A. The volume changes were captured using MRI focused on the hippocampal region
Lubomir Melichercik +6 more
semanticscholar +1 more source
International Immunopharmacology
Sepsis, characterized by high mortality rates, causes over 50 % of acute lung injury (ALI) cases, primarily due to the heightened susceptibility of the lungs during this condition.
Jingqian Su +12 more
semanticscholar +1 more source
Sepsis, characterized by high mortality rates, causes over 50 % of acute lung injury (ALI) cases, primarily due to the heightened susceptibility of the lungs during this condition.
Jingqian Su +12 more
semanticscholar +1 more source

